Target intelligence / Profile preview

CDGSH iron-sulfur domain-containing protein (NEET protein) (NEET)

Target
NEET
Molecular classification
Iron-sulfur cluster protein, CDGSH domain-containing protein, Redox-active protein, Mitochondrial outer membrane protein, Mitochondrial matrix protein
01

Overview

Mitochondrial NEET proteins, also known as CDGSH iron-sulfur domain-containing (CISD) proteins, are a unique class of [2Fe-2S] cluster-binding proteins located primarily in the mitochondria and endoplasmic reticulum. The family consists of three members in humans: CISD1 (mitoNEET), CISD2 (NAF-1), and CISD3 (Miner2), which play critical roles in regulating mitochondrial iron homeostasis, reactive oxygen species (ROS) levels, and bioenergetics (PMID: 17360355, 21825116). These proteins act as redox-sensitive switches that can transfer their iron-sulfur clusters to acceptor proteins, thereby modulating cellular pathways such as apoptosis, autophagy, and ferroptosis. Dysregulation of NEET proteins is implicated in a wide range of pathologies, including type 2 diabetes, neurodegenerative disorders like Parkinson's disease, and various cancers where they support tumor cell proliferation (PMID: 33184277, PMC8021574). NEET proteins were first identified as the mitochondrial targets of the thiazolidinedione class of anti-diabetic drugs, such as pioglitazone, which stabilize the [2Fe-2S] cluster and mitigate mitochondrial dysfunction (PMID: 17360355). Recent therapeutic strategies focus on developing small molecules that either stabilize or destabilize these clusters to treat metabolic diseases or induce ferroptosis in cancer cells. For instance, molecules like Mito-C and M1 have been designed to modulate mitochondrial morphology and iron levels, offering potential treatments for viral infections and metabolic syndrome (PMID: 33184277). Given their central role in maintaining organelle crosstalk and cellular health, NEET proteins represent a promising frontier for disease-modifying therapies in aging and chronic metabolic conditions.

Other names
Mitochondrial NEET proteinsCISD proteinsCDGSH iron-sulfur domain-containing protein 1 (CISD1)CDGSH iron-sulfur domain-containing protein 2 (CISD2)CDGSH iron-sulfur domain-containing protein 3 (CISD3)MitoNEETNutrient-deprivation autophagy factor 1 (NAF-1)Miner1Miner2ERISMiNT
02

Mechanism of action

Drugs targeting NEET proteins typically act by stabilizing or destabilizing the [2Fe-2S] cluster within the CDGSH domain, thereby modulating the rate of cluster transfer to acceptor proteins and regulating mitochondrial iron and ROS levels.

03

Biological functions

Iron-sulfur cluster transferMitochondrial iron homeostasisReactive oxygen species (ROS) regulationApoptosis regulationAutophagy regulationMitochondrial bioenergeticsCalcium homeostasisFerroptosis regulation
04

Disease associations

Type 2 diabetesObesityCancerWolfram Syndrome 2Neurodegenerative diseaseParkinson's diseaseAlzheimer's diseaseAgingCardiovascular diseaseInfection
05

Safety considerations

Off-target effects on other iron-sulfur proteinsPotential mitochondrial toxicity from excessive iron/ROS disruptionComplexity in achieving isoform-specific modulation (CISD1 vs. CISD2)
06

Interacting drugs

Pioglitazone

9 more in the full profile.

07

Biomarkers

Mitochondrial labile iron pool (mLI)Mitochondrial reactive oxygen species (mROS) levelsCISD2 expression levelsMitochondrial morphology (fragmentation/fusion ratio)

Beyond the preview

Go deeper on CDGSH iron-sulfur domain-containing protein (NEET protein) (NEET).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDGSH iron-sulfur domain-containing protein (NEET protein) (NEET).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call